Skip to content

correlation between gastric motility and appetite

The influence of GLP-1 analog, liraglutide, on gastric accommodation, gastric emptying, hunger and the migrating motor complex in healthy volunteers

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2013-004946-41-BE
Enrollment
14
Registered
2014-10-13
Start date
2014-11-19
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers no medical condition

Interventions

Sponsors

KULeuven
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy volunteers (18-45 years) who have no bowel symptoms and who are in good general health are eligible for the study Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 14 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: -they have relevant underlying disease (cardia, pulmonary, metabolic, kidney or liver diseases...) -They have a history of esophageal or gastric surgery, or recurrent or intermittent upper gastrointestinal symptoms (upper abdominal pain, neusea, vomiting, bothersome fullness or early satiation, heartburn, regurgitation...) -They have a history of allergy to several types of drugs or food -They have been treated for depression -There is a possibly of becoming pregnant during the study period

Design outcomes

Primary

MeasureTime frame
Main Objective: We set out to investigate the effect of liraglutide on the relation between gastric accommodation and satiation by measuring the IGP in fasted condition and after the intragastric nutrient drink infusion ;Secondary Objective: not applicable;Primary end point(s): liquid nutrient tolerance to reach maximum satiation return of hunger ;Timepoint(s) of evaluation of this end point: none

Secondary

MeasureTime frame
Secondary end point(s): none;Timepoint(s) of evaluation of this end point: none

Countries

Belgium

Contacts

Public ContactAlessandra Rotondo

KULeuven

alessandra.rotondo@med.kuleuven.be

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026